IP Library Granted Patent US 9,956,410
Granted Patent B2
US 9,956,410 · App. 15/636,381 · Granted May 1, 2018

Methods and apparatus for renal neuromodulation

Inventors: Mark Deem (Mountain View, CA); Denise Zarins (Saratoga, CA); Douglas Sutton (Pacifica, CA); Hanson Gifford, III (Woodside, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY); Benjamin J. Clark (Redwood City, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61N1/36117A61B18/1492A61N1/0551A61N1/32A61N1/327A61N1/36007A61N1/36017A61N1/36128A61N5/00A61B2018/00267A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00613A61B2018/00702A61B2018/00779A61B2018/00791A61B2018/00875A61B2018/00982A61B2018/1435
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,956,410
App. No.
15/636,381
Granted
May 1, 2018
Kind
B2
Abstract

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

Claims (28)

1. A method, comprising:

extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves of a hypertensive human patient; and

delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves innervating the kidney,

wherein delivering electrical energy via the energy delivery elements results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 wherein extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves comprises delivering the distal segment of the device within an introducer, and wherein the method further comprises at least partially withdrawing the introducer before delivering electrical energy via the energy delivery elements.

3. The method of claim 1 wherein the distal segment of the treatment device comprises a pre-formed spiral shape transformable between (a) a low profile delivery configuration and (b) an expanded configuration that tends to assume the spiral shape and positions the energy delivery elements in contact with tissue at or near the renal nerves before delivering electrical energy via the energy delivery elements.

4. The method of claim 1 wherein extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves comprises inserting the distal segment in proximity to the renal nerves and along a renal blood vessel of the patient.

5. The method of claim 1 wherein extravascularly delivering a plurality of energy delivery elements at a distal segment of a treatment device proximate to renal nerves comprises delivering the treatment device over a guidewire.

6. The method of claim 1 wherein delivering electrical energy via the energy delivery elements comprises delivering radio frequency (RF) energy to the renal nerves via the plurality of energy delivery elements.

7. The method of claim 6 wherein delivering radio frequency (RF) energy to the renal nerves via the plurality of energy delivery elements comprises delivering RF energy in a monopolar fashion between one or more of the energy delivery elements and an external ground pad attached to an exterior of the patient.

8. The method of claim 1 , further comprising monitoring a parameter of the treatment device and/or tissue within the patient before and during delivery of electrical energy via the energy delivery elements.

9. The method of claim 8 wherein monitoring a parameter comprises monitoring power, temperature, and/or impedance.

10. The method of claim 9 , further comprising altering delivery of the electrical energy in response to the monitored parameter.

11. The method of claim 1 wherein delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves comprises ablating renal nerves of the patient.

12. The method of claim 1 wherein delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves comprises partially ablating renal nerves of the patient.

13. The method of claim 1 wherein delivering electrical energy via the energy delivery elements to attenuate neural traffic along the renal nerves reduces neural signaling to and from a kidney of the patient.

14. The method of claim 1 wherein attenuating neural traffic along the renal nerves comprises at least partially denervating a kidney of the patient.

15. The method of claim 1 , further comprising removing the treatment device from the patient after delivering the electrical energy to conclude the procedure.

16. A method for treating a hypertensive human patient, the method comprising:

positioning a plurality of electrodes at a distal region of a catheter at an extravascular location within a human patient and adjacent to neural fibers innervating a kidney of the patient;

transforming the distal region of the catheter from a low-profile delivery state to an expanded treatment state,

wherein, in the treatment state, the distal region of the catheter is sized and shaped to place the plurality of electrodes in contact with target tissue at or near the neural fibers; and

ablating the neural fibers innervating the kidney via radio frequency (RF) energy from the electrodes.

17. The method of claim 16 wherein ablating the neural fibers innervating the kidney significantly improves a measurable physiological parameter associated with the hypertension of the patient.

18. The method of claim 16 wherein ablating the neural fibers innervating the kidney results in a therapeutically beneficial reduction in blood pressure of the patient.

19. The method of claim 16 wherein ablating the neural fibers innervating the kidney comprises at least partially denervating the kidney of the patient.

20. The method of claim 16 wherein positioning a plurality of electrodes at a distal region of a catheter at an extravascular location comprises positioning the plurality of electrodes under visual guidance.

21. The method of claim 16 wherein positioning a plurality of electrodes at a distal region of a catheter at an extravascular location comprises positioning the plurality of electrodes under guidance chosen from the group consisting of computed tomographic, radiographic, ultrasonic, angiographic, laparoscopic and combinations thereof.

Assignments (4)
CHANGE OF NAME Recorded Feb 28, 2018
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 045472/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2018
From: DEMARAIS, DENISE; DEEM, MARK; SUTTON, DOUGLAS; GIFFORD, HANSON, III; LEVIN, HOWARD R.; GELFAND, MARK; CLARK, BENJAMIN J.
To: ARDIAN, INC.
Reel/Frame 044643/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2018
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 044643/0487 →
CHANGE OF NAME Recorded Jan 17, 2018
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 045084/0049 →
Continuity (15)
Continuation 15254340 · Sep 1, 2016
Continuation 14878898 · Oct 8, 2015
Continuation 14279023 · May 15, 2014
Continuation 13942223 · Jul 15, 2013
Continuation 13361542 · Jan 30, 2012
Division 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20170361100A1 · Dec 21, 2017